€7.4M EU grant boosts development of vaccines against Marburg viruses
International research consortium receives highly endowed Horizon Europe funding for the development of vaccines against Marburg viruses.
Oxidized amino acids signal damaged photosynthesis proteins for repair
Photosynthesis refers to the fundamental biological process of the conversion of light energy into chemical energy by chlorophyll (a green…
Bridging ideas to IND: Nona Biosciences’ year of impact in biotechnology
Amidst a backdrop of industry-wide hurdles like inflation, talent scarcities, and stringent regulatory landscapes, Nona Biosciences is showing great promise…
Sphere Fluidics appoints Dr. Graeme Daniels as Vice President of Sales and Marketing
Appointment to senior leadership team strengthens the Company’s plans for continued growth to advance its commercial ambitions.
Deep learning designs high-affinity protein binders for bioactive helical peptides
A new study Dec. 18 in Nature reports an AI-driven advance in biotechnology with implications for drug development, disease detection,…
Transgenic carrots producing nisin protein show promise as natural food preservatives
Study explores the production of nisin protein in transgenic carrots, demonstrating its potential as a natural preservative effective against bacterial…
Unlocking the secrets of our “dark genome”: Scientists crack the code of LINE-1
A multidisciplinary study published in Nature has elucidated the structure of the machinery responsible for writing much of our "dark…
Gavi commits more than US$1.8 billion to support vaccine production in Africa
Gavi, the vaccine alliance, says it has committed more than US$1.8 billion to support vaccine production in Africa, a move…
Bottlenecks in Nucleic Acid Extraction: A Multi-Industrial approach with HiMedia Labs
An interview with Dr. Rajas Warke, Director of Molecular Biology and virology at HiMedia Labs.
SolasCure demonstrates proof-of-concept in Phase lla safety trial of Aurase Wound Gel
SolasCure today announced the results of its proof-of-concept, first-in-human, Phase IIa safety study.